Summit Trail Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,456	Closed	-$763K	–	173
2018 Q3	$763K	Sell	4,456 -113	-2%	-$19.3K	0.17%	72
2018 Q2	$590K	Sell	4,569 -19,117	-81%	-$2.47M	0.21%	59
2018 Q1	$1.95M	Buy	23,686 +2,284	+11%	+$188K	0.33%	60
2017 Q4	$2.14M	Buy	+21,402	New	+$2.14M	0.27%	69